Clinical Trial Update: Safety Study of Pritumumab in Brain Cancer [Phase 1]

View source ↗

Summary

Phase 1 safety study of Pritumumab in adult brain cancer patients with malignant primary brain tumors and brain metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Malignant Brain Tumors

Drugs mentioned

• Pritumumab (pritumumab)

Snippet

Sponsor: Nascent Biotech | Conditions: Malignant Primary Brain Tumors, Brain Metastases, Adult | Phase 1 | Status: COMPLETED